Review





Similar Products

94
Miltenyi Biotec cd80
Proposed model illustrating the effects of EZH2 inhibition across multiple joint compartments in osteoarthritis. In OA fibroblast-like synoviocytes (FLS), increased EZH2 and H3K27me3 levels were associated with inflammatory and catabolic responses, which were reduced by pharmacological EZH2 inhibition with EPZ-6438. In human OA FLS, EPZ-6438 decreased inflammatory, catabolic and pain-associated mediators, including IL1B, MMP13, NGF and NTN1, reduced LDHA expression and increased autophagy-associated responses. Proteomic and ChIP-seq analyses further identified inflammatory, metabolic and axon guidance-related pathways, including inflammation-dependent EZH2 recruitment at the PAX6 locus. EZH2 inhibition also reduced inflammatory activation of macrophages and osteoclastogenesis in OA-derived bone marrow cells. Collectively, these findings support a broader role for EZH2 in inflammatory, catabolic and osteoimmune responses across multiple OA-relevant cellular compartments. The identification of PAX6, NTN1 and axon guidance-related pathways highlights neuro-associated molecular programs that may be relevant to pain-associated responses, although their direct contribution to pain or sensory nerve remodeling was not assessed in this study. The reduced structural joint damage and pain-related behaviors observed following EZH2 inhibition in the MIA-induced OA model are consistent with this multicellular framework
Cd80, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd80/CD80+Antibody%2C+anti-mouse%2C+REAfinity/pmc13694607-279-21-25
Average 94 stars, based on 1 article reviews
cd80 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
InvivoGen jurkat cells
Proposed model illustrating the effects of EZH2 inhibition across multiple joint compartments in osteoarthritis. In OA fibroblast-like synoviocytes (FLS), increased EZH2 and H3K27me3 levels were associated with inflammatory and catabolic responses, which were reduced by pharmacological EZH2 inhibition with EPZ-6438. In human OA FLS, EPZ-6438 decreased inflammatory, catabolic and pain-associated mediators, including IL1B, MMP13, NGF and NTN1, reduced LDHA expression and increased autophagy-associated responses. Proteomic and ChIP-seq analyses further identified inflammatory, metabolic and axon guidance-related pathways, including inflammation-dependent EZH2 recruitment at the PAX6 locus. EZH2 inhibition also reduced inflammatory activation of macrophages and osteoclastogenesis in OA-derived bone marrow cells. Collectively, these findings support a broader role for EZH2 in inflammatory, catabolic and osteoimmune responses across multiple OA-relevant cellular compartments. The identification of PAX6, NTN1 and axon guidance-related pathways highlights neuro-associated molecular programs that may be relevant to pain-associated responses, although their direct contribution to pain or sensory nerve remodeling was not assessed in this study. The reduced structural joint damage and pain-related behaviors observed following EZH2 inhibition in the MIA-induced OA model are consistent with this multicellular framework
Jurkat Cells, supplied by InvivoGen, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd80/CTLA-4%2FCD80+Bio-IC/pm42546824-117-15-18
Average 94 stars, based on 1 article reviews
jurkat cells - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Elabscience Biotechnology cd80 fitc
Proposed model illustrating the effects of EZH2 inhibition across multiple joint compartments in osteoarthritis. In OA fibroblast-like synoviocytes (FLS), increased EZH2 and H3K27me3 levels were associated with inflammatory and catabolic responses, which were reduced by pharmacological EZH2 inhibition with EPZ-6438. In human OA FLS, EPZ-6438 decreased inflammatory, catabolic and pain-associated mediators, including IL1B, MMP13, NGF and NTN1, reduced LDHA expression and increased autophagy-associated responses. Proteomic and ChIP-seq analyses further identified inflammatory, metabolic and axon guidance-related pathways, including inflammation-dependent EZH2 recruitment at the PAX6 locus. EZH2 inhibition also reduced inflammatory activation of macrophages and osteoclastogenesis in OA-derived bone marrow cells. Collectively, these findings support a broader role for EZH2 in inflammatory, catabolic and osteoimmune responses across multiple OA-relevant cellular compartments. The identification of PAX6, NTN1 and axon guidance-related pathways highlights neuro-associated molecular programs that may be relevant to pain-associated responses, although their direct contribution to pain or sensory nerve remodeling was not assessed in this study. The reduced structural joint damage and pain-related behaviors observed following EZH2 inhibition in the MIA-induced OA model are consistent with this multicellular framework
Cd80 Fitc, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd80/FITC+Anti-Mouse+CD80+Antibody/pm42909153-502-24-26
Average 94 stars, based on 1 article reviews
cd80 fitc - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
ABclonal Biotechnology bv 2 activation
Proposed model illustrating the effects of EZH2 inhibition across multiple joint compartments in osteoarthritis. In OA fibroblast-like synoviocytes (FLS), increased EZH2 and H3K27me3 levels were associated with inflammatory and catabolic responses, which were reduced by pharmacological EZH2 inhibition with EPZ-6438. In human OA FLS, EPZ-6438 decreased inflammatory, catabolic and pain-associated mediators, including IL1B, MMP13, NGF and NTN1, reduced LDHA expression and increased autophagy-associated responses. Proteomic and ChIP-seq analyses further identified inflammatory, metabolic and axon guidance-related pathways, including inflammation-dependent EZH2 recruitment at the PAX6 locus. EZH2 inhibition also reduced inflammatory activation of macrophages and osteoclastogenesis in OA-derived bone marrow cells. Collectively, these findings support a broader role for EZH2 in inflammatory, catabolic and osteoimmune responses across multiple OA-relevant cellular compartments. The identification of PAX6, NTN1 and axon guidance-related pathways highlights neuro-associated molecular programs that may be relevant to pain-associated responses, although their direct contribution to pain or sensory nerve remodeling was not assessed in this study. The reduced structural joint damage and pain-related behaviors observed following EZH2 inhibition in the MIA-induced OA model are consistent with this multicellular framework
Bv 2 Activation, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd80/CD80+Rabbit+pAb/10__20517_slash_evcna__2026__91-105-2-17
Average 94 stars, based on 1 article reviews
bv 2 activation - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Novus Biologicals cd80
Proposed model illustrating the effects of EZH2 inhibition across multiple joint compartments in osteoarthritis. In OA fibroblast-like synoviocytes (FLS), increased EZH2 and H3K27me3 levels were associated with inflammatory and catabolic responses, which were reduced by pharmacological EZH2 inhibition with EPZ-6438. In human OA FLS, EPZ-6438 decreased inflammatory, catabolic and pain-associated mediators, including IL1B, MMP13, NGF and NTN1, reduced LDHA expression and increased autophagy-associated responses. Proteomic and ChIP-seq analyses further identified inflammatory, metabolic and axon guidance-related pathways, including inflammation-dependent EZH2 recruitment at the PAX6 locus. EZH2 inhibition also reduced inflammatory activation of macrophages and osteoclastogenesis in OA-derived bone marrow cells. Collectively, these findings support a broader role for EZH2 in inflammatory, catabolic and osteoimmune responses across multiple OA-relevant cellular compartments. The identification of PAX6, NTN1 and axon guidance-related pathways highlights neuro-associated molecular programs that may be relevant to pain-associated responses, although their direct contribution to pain or sensory nerve remodeling was not assessed in this study. The reduced structural joint damage and pain-related behaviors observed following EZH2 inhibition in the MIA-induced OA model are consistent with this multicellular framework
Cd80, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd80/B7-1%2FCD80+Antibody+(2D10%2E4)+%5BAllophycocyanin%2FCy7%5D/pm42834086-288-31-33
Average 94 stars, based on 1 article reviews
cd80 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Elabscience Biotechnology anti cd80
Proposed model illustrating the effects of EZH2 inhibition across multiple joint compartments in osteoarthritis. In OA fibroblast-like synoviocytes (FLS), increased EZH2 and H3K27me3 levels were associated with inflammatory and catabolic responses, which were reduced by pharmacological EZH2 inhibition with EPZ-6438. In human OA FLS, EPZ-6438 decreased inflammatory, catabolic and pain-associated mediators, including IL1B, MMP13, NGF and NTN1, reduced LDHA expression and increased autophagy-associated responses. Proteomic and ChIP-seq analyses further identified inflammatory, metabolic and axon guidance-related pathways, including inflammation-dependent EZH2 recruitment at the PAX6 locus. EZH2 inhibition also reduced inflammatory activation of macrophages and osteoclastogenesis in OA-derived bone marrow cells. Collectively, these findings support a broader role for EZH2 in inflammatory, catabolic and osteoimmune responses across multiple OA-relevant cellular compartments. The identification of PAX6, NTN1 and axon guidance-related pathways highlights neuro-associated molecular programs that may be relevant to pain-associated responses, although their direct contribution to pain or sensory nerve remodeling was not assessed in this study. The reduced structural joint damage and pain-related behaviors observed following EZH2 inhibition in the MIA-induced OA model are consistent with this multicellular framework
Anti Cd80, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd80/FITC+Anti-Mouse+CD80+Antibody/pm42829139-144-17-18
Average 94 stars, based on 1 article reviews
anti cd80 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Elabscience Biotechnology pe anti mouse cd80
Proposed model illustrating the effects of EZH2 inhibition across multiple joint compartments in osteoarthritis. In OA fibroblast-like synoviocytes (FLS), increased EZH2 and H3K27me3 levels were associated with inflammatory and catabolic responses, which were reduced by pharmacological EZH2 inhibition with EPZ-6438. In human OA FLS, EPZ-6438 decreased inflammatory, catabolic and pain-associated mediators, including IL1B, MMP13, NGF and NTN1, reduced LDHA expression and increased autophagy-associated responses. Proteomic and ChIP-seq analyses further identified inflammatory, metabolic and axon guidance-related pathways, including inflammation-dependent EZH2 recruitment at the PAX6 locus. EZH2 inhibition also reduced inflammatory activation of macrophages and osteoclastogenesis in OA-derived bone marrow cells. Collectively, these findings support a broader role for EZH2 in inflammatory, catabolic and osteoimmune responses across multiple OA-relevant cellular compartments. The identification of PAX6, NTN1 and axon guidance-related pathways highlights neuro-associated molecular programs that may be relevant to pain-associated responses, although their direct contribution to pain or sensory nerve remodeling was not assessed in this study. The reduced structural joint damage and pain-related behaviors observed following EZH2 inhibition in the MIA-induced OA model are consistent with this multicellular framework
Pe Anti Mouse Cd80, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd80/PE+Anti-Mouse+CD80+Antibody/10__1038_slash_s41467___026___77873___7-389-7-53
Average 94 stars, based on 1 article reviews
pe anti mouse cd80 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
Proteintech cd80
Time-dependent differentiation and phenotypic maturation of human monocytes into macrophages. (A) Schematic of the experimental timeline. Upper panel: culture conditions; lower panel: analyses at each time point. Analyses on days 6 and 7 were conducted prior to polarization. (B) Classification of monocyte subsets (CD14/CD16) and macrophages phenotypes (CD68/CD86/CD163). (C) Flow cytometric analysis of monocyte subsets at days 0, 4, 6, and 7 without polarization or neutrophils. Dot plots show CD14/CD16, CD14 + CD86/CD163, CD86/CD163, and CD14/CD68. (D) Representative immunofluorescence images on days 4 and 7 (pre-polarization) under IFN-γ/LPS and IL-4/IL-13 conditions; DAPI (blue), CD68 (green), <t>CD80</t> or CD206 (red). Scale bars, 100 µm. (E) Quantification of CD68 + CD86 + and CD68 + CD163 + macrophages under IFN-γ/LPS and IL-4/IL-13 conditions on day 7 (pre-polarization). n = 5 independent donors.
Cd80, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd80/CD80%2FB7-1+Antibody/pmc13574648-110-10-13
Average 96 stars, based on 1 article reviews
cd80 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
Elabscience Biotechnology cd80 pe
Time-dependent differentiation and phenotypic maturation of human monocytes into macrophages. (A) Schematic of the experimental timeline. Upper panel: culture conditions; lower panel: analyses at each time point. Analyses on days 6 and 7 were conducted prior to polarization. (B) Classification of monocyte subsets (CD14/CD16) and macrophages phenotypes (CD68/CD86/CD163). (C) Flow cytometric analysis of monocyte subsets at days 0, 4, 6, and 7 without polarization or neutrophils. Dot plots show CD14/CD16, CD14 + CD86/CD163, CD86/CD163, and CD14/CD68. (D) Representative immunofluorescence images on days 4 and 7 (pre-polarization) under IFN-γ/LPS and IL-4/IL-13 conditions; DAPI (blue), CD68 (green), <t>CD80</t> or CD206 (red). Scale bars, 100 µm. (E) Quantification of CD68 + CD86 + and CD68 + CD163 + macrophages under IFN-γ/LPS and IL-4/IL-13 conditions on day 7 (pre-polarization). n = 5 independent donors.
Cd80 Pe, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd80/PE+Anti-Mouse+CD80+Antibody/10__1016_slash_j__cej__2026__182168-49-20-26
Average 94 stars, based on 1 article reviews
cd80 pe - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

Image Search Results


Proposed model illustrating the effects of EZH2 inhibition across multiple joint compartments in osteoarthritis. In OA fibroblast-like synoviocytes (FLS), increased EZH2 and H3K27me3 levels were associated with inflammatory and catabolic responses, which were reduced by pharmacological EZH2 inhibition with EPZ-6438. In human OA FLS, EPZ-6438 decreased inflammatory, catabolic and pain-associated mediators, including IL1B, MMP13, NGF and NTN1, reduced LDHA expression and increased autophagy-associated responses. Proteomic and ChIP-seq analyses further identified inflammatory, metabolic and axon guidance-related pathways, including inflammation-dependent EZH2 recruitment at the PAX6 locus. EZH2 inhibition also reduced inflammatory activation of macrophages and osteoclastogenesis in OA-derived bone marrow cells. Collectively, these findings support a broader role for EZH2 in inflammatory, catabolic and osteoimmune responses across multiple OA-relevant cellular compartments. The identification of PAX6, NTN1 and axon guidance-related pathways highlights neuro-associated molecular programs that may be relevant to pain-associated responses, although their direct contribution to pain or sensory nerve remodeling was not assessed in this study. The reduced structural joint damage and pain-related behaviors observed following EZH2 inhibition in the MIA-induced OA model are consistent with this multicellular framework

Journal: Molecular Biomedicine

Article Title: EZH2 coordinates inflammatory and pain-associated pathways across joint compartments in osteoarthritis

doi: 10.1186/s43556-026-00643-w

Figure Lengend Snippet: Proposed model illustrating the effects of EZH2 inhibition across multiple joint compartments in osteoarthritis. In OA fibroblast-like synoviocytes (FLS), increased EZH2 and H3K27me3 levels were associated with inflammatory and catabolic responses, which were reduced by pharmacological EZH2 inhibition with EPZ-6438. In human OA FLS, EPZ-6438 decreased inflammatory, catabolic and pain-associated mediators, including IL1B, MMP13, NGF and NTN1, reduced LDHA expression and increased autophagy-associated responses. Proteomic and ChIP-seq analyses further identified inflammatory, metabolic and axon guidance-related pathways, including inflammation-dependent EZH2 recruitment at the PAX6 locus. EZH2 inhibition also reduced inflammatory activation of macrophages and osteoclastogenesis in OA-derived bone marrow cells. Collectively, these findings support a broader role for EZH2 in inflammatory, catabolic and osteoimmune responses across multiple OA-relevant cellular compartments. The identification of PAX6, NTN1 and axon guidance-related pathways highlights neuro-associated molecular programs that may be relevant to pain-associated responses, although their direct contribution to pain or sensory nerve remodeling was not assessed in this study. The reduced structural joint damage and pain-related behaviors observed following EZH2 inhibition in the MIA-induced OA model are consistent with this multicellular framework

Article Snippet: The following antibodies were used for immune cell characterization: CD11b (REA592 VioBlue, 130–113–810, Miltenyi Biotec), F4/80 (REA126 PE-Vio770, 130–118–459, Miltenyi Biotec), CD80 (REA983 APC-Vio770, 130–116–463, Miltenyi Biotec), CD86 (REA1190 PE, 130–122–129, Miltenyi Biotec), MHC-II (REA813 FITC, 130–112–386, Miltenyi Biotec), CD38 (REA616 PerCP-Vio700, 130–109–260, Miltenyi Biotec), and iNOS (REA982 APC, 130–116–423, Miltenyi Biotec).

Techniques: Inhibition, Expressing, ChIP-sequencing, Activation Assay, Derivative Assay

Time-dependent differentiation and phenotypic maturation of human monocytes into macrophages. (A) Schematic of the experimental timeline. Upper panel: culture conditions; lower panel: analyses at each time point. Analyses on days 6 and 7 were conducted prior to polarization. (B) Classification of monocyte subsets (CD14/CD16) and macrophages phenotypes (CD68/CD86/CD163). (C) Flow cytometric analysis of monocyte subsets at days 0, 4, 6, and 7 without polarization or neutrophils. Dot plots show CD14/CD16, CD14 + CD86/CD163, CD86/CD163, and CD14/CD68. (D) Representative immunofluorescence images on days 4 and 7 (pre-polarization) under IFN-γ/LPS and IL-4/IL-13 conditions; DAPI (blue), CD68 (green), CD80 or CD206 (red). Scale bars, 100 µm. (E) Quantification of CD68 + CD86 + and CD68 + CD163 + macrophages under IFN-γ/LPS and IL-4/IL-13 conditions on day 7 (pre-polarization). n = 5 independent donors.

Journal: Frontiers in Immunology

Article Title: Macrophage polarization modulates neutrophil extracellular trap dynamics and reciprocal macrophage responses

doi: 10.3389/fimmu.2026.1850388

Figure Lengend Snippet: Time-dependent differentiation and phenotypic maturation of human monocytes into macrophages. (A) Schematic of the experimental timeline. Upper panel: culture conditions; lower panel: analyses at each time point. Analyses on days 6 and 7 were conducted prior to polarization. (B) Classification of monocyte subsets (CD14/CD16) and macrophages phenotypes (CD68/CD86/CD163). (C) Flow cytometric analysis of monocyte subsets at days 0, 4, 6, and 7 without polarization or neutrophils. Dot plots show CD14/CD16, CD14 + CD86/CD163, CD86/CD163, and CD14/CD68. (D) Representative immunofluorescence images on days 4 and 7 (pre-polarization) under IFN-γ/LPS and IL-4/IL-13 conditions; DAPI (blue), CD68 (green), CD80 or CD206 (red). Scale bars, 100 µm. (E) Quantification of CD68 + CD86 + and CD68 + CD163 + macrophages under IFN-γ/LPS and IL-4/IL-13 conditions on day 7 (pre-polarization). n = 5 independent donors.

Article Snippet: For polarization: CD68 (clone D4B9C, Cell Signaling Technology, 26042SF, 1:200), CD80 (clone 1E2F10, Proteintech, 66406-1-Ig, 1:50), CD206 (clone 2A6A10, Proteintech, 60143-1-Ig, 1:200), For NETs: Myeloperoxidase (MPO; rabbit polyclonal, Abcam, ab9535, 1:150), double-stranded DNA (dsDNA; clone 35I9 DNA, Abcam, ab27156, 1:500), neutrophil elastase (NE; clone NP57, Abcam, ab254178, 1:100), and citrullinated histone H3 (H3Cit; rabbit polyclonal, Abcam, ab5103, 1:100).

Techniques: Analysis, Immunofluorescence, Co-Culture, Flow Cytometry

Neutrophil-dependent modulation of macrophage polarization states. (A) Schematic of macrophage polarization states and surface marker profiles. M2 subsets (M2a–d) are defined by differential expression of CD163, CD206, and CD86. (B) Representative immunofluorescence images under IFN-γ/LPS and IL-4/IL-13 conditions after 24 h neutrophil co-culture; DAPI (blue), CD68 (green), CD80 (red). Scale bars, 100 µm. (C) Quantification of macrophage subsets (CD86 – CD163 + [M2-like], CD86 + CD163 + [intermediate], CD86 + CD163 – [M1-like]) following co-culture with neutrophils under concurrently polarized and pre-polarized conditions. (D) Representative flow cytometry histograms of CD86 and CD163 mean fluorescence intensity (MFI) in CD14 + CD16 + and CD14 + CD16 – macrophage subsets. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (Kruskal–Wallis test followed by Dunn’s multiple comparisons test). n = 5 independent donors.

Journal: Frontiers in Immunology

Article Title: Macrophage polarization modulates neutrophil extracellular trap dynamics and reciprocal macrophage responses

doi: 10.3389/fimmu.2026.1850388

Figure Lengend Snippet: Neutrophil-dependent modulation of macrophage polarization states. (A) Schematic of macrophage polarization states and surface marker profiles. M2 subsets (M2a–d) are defined by differential expression of CD163, CD206, and CD86. (B) Representative immunofluorescence images under IFN-γ/LPS and IL-4/IL-13 conditions after 24 h neutrophil co-culture; DAPI (blue), CD68 (green), CD80 (red). Scale bars, 100 µm. (C) Quantification of macrophage subsets (CD86 – CD163 + [M2-like], CD86 + CD163 + [intermediate], CD86 + CD163 – [M1-like]) following co-culture with neutrophils under concurrently polarized and pre-polarized conditions. (D) Representative flow cytometry histograms of CD86 and CD163 mean fluorescence intensity (MFI) in CD14 + CD16 + and CD14 + CD16 – macrophage subsets. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (Kruskal–Wallis test followed by Dunn’s multiple comparisons test). n = 5 independent donors.

Article Snippet: For polarization: CD68 (clone D4B9C, Cell Signaling Technology, 26042SF, 1:200), CD80 (clone 1E2F10, Proteintech, 66406-1-Ig, 1:50), CD206 (clone 2A6A10, Proteintech, 60143-1-Ig, 1:200), For NETs: Myeloperoxidase (MPO; rabbit polyclonal, Abcam, ab9535, 1:150), double-stranded DNA (dsDNA; clone 35I9 DNA, Abcam, ab27156, 1:500), neutrophil elastase (NE; clone NP57, Abcam, ab254178, 1:100), and citrullinated histone H3 (H3Cit; rabbit polyclonal, Abcam, ab5103, 1:100).

Techniques: Marker, Quantitative Proteomics, Immunofluorescence, Co-culture Assay, Flow Cytometry, Fluorescence